NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

about

NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

Item

http://www.wikidata.org/entity/Q38694253

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

@en

type

Item

label

NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

@en

prefLabel

NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

@en

P1476

NanoMIL-100(Fe) containing docetaxel for breast cancer therapy.

@en

P2093

Mahmood Jeddi-Tehrani

http://www.w3.org/2001/XMLSchema#string

Mahsa Rezaei

http://www.w3.org/2001/XMLSchema#string

Rassoul Dinarvand

http://www.w3.org/2001/XMLSchema#string

Reyhaneh Varshochian

http://www.w3.org/2001/XMLSchema#string

P2860

Chemical basis of interactions between engineered nanoparticles and biological systems

Synthesis and Electrospraying of Nanoscale MOF (Metal Organic Framework) for High-Performance CO2 Adsorption Membrane

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

Towards an improved anti-HIV activity of NRTI via metal-organic frameworks nanoparticles.

CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system.

More effective nanomedicines through particle design

A simple method to improve the stability of docetaxel micelles

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.

Metal-organic frameworks as potential drug delivery systems.

Applications of nanoparticle systems in gene delivery and gene therapy.

P304

1390-1401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21691401.2017.1369425

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alireza Abbasi

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28838252

http://www.w3.org/2001/XMLSchema#string